June 2005

Wells joins UCSF as first Hind Professor

James Wells, PhD, a leader in the development of new technologies to aid drug discovery and protein engineering, joins UCSF as the first holder of the Harry Wm. and Diana V. Hind Distinguished Professorship in Pharmaceutical Sciences. Wells will hold joint faculty appointments in the Schools of Pharmacy and Medicine. Wells is a member of the National Academy of Sciences and co-founder of Sunesis, the South San Francisco pharmaceutical company.

UCSF School of Pharmacy tops NIH funding

The UCSF School of Pharmacy was the largest recipient of 2004 research funding from the National Institutes of Health (NIH) among pharmacy schools in the United States. The School's 2004 total NIH award funding was US$23.5 million.

"The 2004 ranking marks the 25th consecutive year we've received top NIH funding," said Mary Anne Koda-Kimble, PharmD, dean, UCSF School of Pharmacy. The 1979 figure was US$1.7 million. This is quite an accomplishment."